Atlantic Technological University and Resolution Medical Collaborate to bring Advanced BioSimulation Technologies to the MedTech Sector
Atlantic Technological University (ATU) is pleased to announce a partnership with Resolution Medical and LifeTec Group to bring enhanced expertise and capabilities in a range of device development and BioSimulation Technologies to Galway. This complements the existing...
Breakthrough offers palliative comfort in familiar surrounds
Maximising the quality of life, protecting independence and guarding the dignity of people receiving palliative care are the driving forces behind a new life-changing medical device that has been developed by a Galway start-up. CEO of Symphysis, Tim Jones, said it was...
NUA Surgical Strengthens Leadership and R&D Teams with Key Appointments
Galway-based medical device company expands board and R&D capabilities with three appointments. NUA Surgical has recently made significant additions to both its leadership team and R&D capabilities, appointing a new Non-Executive Director and welcoming two...
SymPhysis Medical Honoured to receive multiple LifeScience Industry Accolades During a Celebrated Summer Awards Season
SymPhysis Medical were thrilled to win both the Innovation Award at the Future Health Summit and the Patient Impact Award at the Life Science Industry Awards this summer! The Future Health Summit took place in Dublin on the 28th-29th of May and the Life Science...
CroíValve Announces Funding from Horizon Europe EIC Accelerator
CroíValve, a pioneering medical device company innovating a better way to help more patients suffering from Tricuspid Regurgitation (TR), were awarded funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Programme. Part of the EU’s Horizon...
Atlantic Technological University Signs Strategic Agreement with University of Illinois Chicago to Advance Urological Innovation
Atlantic Technological University (ATU) in Ireland and the University of Illinois Chicago (UIC) in the US have signed a Memorandum of Agreement (MoA) supporting a cross-institutional partnership focused on Urological Innovation, furthering bilateral collaboration in...
CroíValve Announces First Implant of a Novel Minimally Invasive Device for Tricuspid Regurgitation in US Early Feasibility Study
ATU iHub client company CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR), announced the first patient treated with the DUO™ System as part of the TANDEM...
AuriGen Medical Pioneers Next-Generation Atrial Fibrillation Technology with First-in-Human Success
AuriGen Medical, a medical device company specializing in left atrial appendage occlusion (LAAO) technology, today announced the successful treatment of their first patient in its first-in-human clinical study. The procedure, performed by Dr Matt O’Connor,...
